|
Report No. : |
345833 |
|
Report Date : |
20.10.2015 |
IDENTIFICATION DETAILS
|
Name : |
MEDICRAFT PHARMACEUTICALS (PVT.) LIMITED |
|
|
|
|
Registered Office : |
Plot # 126-B, Industrial Estate, Jamrud Road, Peshawar |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Year of Establishment : |
1991 |
|
|
|
|
Com. Reg. No.: |
0024422 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture & Marketing of Pharmaceutical Products. |
|
|
|
|
No. of Employees : |
102 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made on
e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Pakistan |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Business Name |
MEDICRAFT PHARMACEUTICALS
(PVT.) LIMITED |
|
Registered
Address & Factory |
|
Plot # 126-B, Industrial Estate, Jamrud Road, Peshawar, Pakistan |
|
Tel # |
92 (91) 5816000, 5891238 |
|
Fax # |
92 (91) 5891238 |
|
a. |
Nature of Business |
Manufacture & Marketing of
Pharmaceutical Products |
|
b. |
Year Established |
1991 |
|
c. |
Registration # |
0024422 |
|
In Peshawar at present |
|
Ghafoor & Co. (Chartered
Accountants) |
|
Subject Company was established as a Private Limited Company in 1991 |
|
Authorized Capital |
Rs. 30,000,000/- divided into 300,000 shares of Rs. 100/- each |
|
Issued & Paid up Capital |
Rs 13,510,000/- divided into 135,100 shares of Rs. 100/- each |
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Ishtiaq Ahmed Mr. Aftab Ahmed Mr. Ashfaq Ahmed Mr. Imtiaz Ahmed |
Pakistani Pakistani Pakistani Pakistani |
Plot # 126-B,
Industrial Estate, Jamrud Road, Peshawar Plot # 126-B,
Industrial Estate, Jamrud Road, Peshawar Plot # 126-B,
Industrial Estate, Jamrud Road, Peshawar Plot # 126-B,
Industrial Estate, Jamrud Road, Peshawar |
Business Business Business Business |
Chief Executive Director Director Director |
|
Names |
No. of Shares |
|
Mr. Aftab Ahmed Mr. Ishtiaq Ahmed Mr. Ashfaq Ahmed Mr. Imtiaz Ahmed Mrs. Ashrafat Begum Mrs. Abida Aftab Mrs. Robina Ishtiaq |
15,733 46,507 41,355 27,105 1,080 920 750 |
A. Subsidiary
None
B. Associated Companies
- Do
-
Manufacture & Marketing of Pharmaceutical Products by its brand name
including ALLERGON, AMCHLO, AMNORIL, ANHIBIT, ASTHACURE, BACTIMED, BACTIRID,
BIOMED, BONEMED, CARDIOWEL, CEFOMED, CEFPOMED, CHLOROMED, CIPROKING, CIPROMED,
102
|
Year |
In Pak Rupees |
|
2014 |
90,000,000/- (Estimated) |
Subject import globally from Companies belongs to India, China &
European Countries
|
Major customers are Private & Government Hospitals, Distribution
Companies etc |
|
(1) Habib Bank Limited, Pakistan. (2) Dubai Islamic
Bank Pak Limited, Pakistan. (3) Bank Alfalah Limited, Pakistan. (4) MCB Bank Limited, Pakistan. (5) United Bank
Limited, Pakistan. |
·
Khyber Pakhtoonkwa
Chamber of Commerce & Industry.(KPCCI)
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 104.45 |
|
UK Pound |
1 |
Rs. 160.50 |
|
Euro |
1 |
Rs. 118.25 |
Subject Company was established in 1991 and is engaged in manufacture
& marketing of Pharmaceutical Products. Trade relations are reported as fair.
Subject can be considered for normal business dealings at usual trade terms and
conditions.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.64.82 |
|
|
1 |
Rs.100.12 |
|
Euro |
1 |
Rs.73.75 |
INFORMATION DETAILS
|
Analysis Done by
: |
KAS |
|
|
|
|
Report Prepared
by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major sections
of this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.